Industry NewsFormedix has launched all-in-one cloud-based clinical metadata repository and study automation platform to simplify and expedite clinical trial design and build
Industry NewsNew phase III data shows investigational antibody cocktail reduced hospitalization or death by 70% in non-hospitalized patients with COVID-19
Product NewsThermo Fisher Scientific completes FDA listing for the Applied Biosystems QuantStudio 5 Dx Real-Time PCR System
Industry NewsAptamer Group and Mologic partner to develop aptamer-based SARS-CoV-2 rapid antigen test
Industry NewsBeckman Coulter's SARS-CoV-2 IgG II antibody test receives Emergency Use Authorization from FDA
Industry NewsUSA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective
Industry NewsThermo Fisher Scientific collaborates with Protein Metrics to optimize data analysis in biopharma
Product NewsAbbott introduces NeuroSphere™ Virtual Clinic, first-of-its-kind remote neuromodulation patient-care technology in the U.S.
Industry News‘Backup’ pacemaker discovery in goats could have important implications for human hearts
Product NewsAbbott receives FDA EUA for test that detects SARS-CoV-2 and three other respiratory infections
Industry NewsNovel pooled testing strategies can significantly increase ability to identify COVID-19 infections
Industry NewsRedHill Biopharma announces planned expansion of Opaganib global phase 2/3 COVID-19 study to the U.S
Editorial ArticleThe Magnificent Seven: Top-rated lab products awarded new Seals of Quality at Virtual Analytical Summit 2021
Industry NewsAnanda Devices, Molecular Devices collaborate to automate imaging and customize analysis of nervous system on-a-chip
Industry NewsPre Diagnostics completes proof of concept study for its intracellular PreADx immunoassay for detection of Alzheimer’s Disease
Product NewsPerkinElmer changes COVID-19 rapid testing landscape with highly sensitive point of care antigen test for mass screening
Editorial ArticleNew ultra-sensitive, automated immunoassays to streamline biopharma clinical assay development
Industry NewsRedHill Biopharma announces first patient dosed in U.S. Phase 2/3 COVID-19 outpatient study with RHB-107
